Get started
Author

Narendra R. Nagpure

Observed names: Nagpure, Narendra, Narendra Nagpure, Narendra Raju Nagpure
ORCID: 0009-0003-8399-7618
Observed ORCID: 0009-0003-8399-7618
OpenAlex ID: A5116774671
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
2025 · Chandrakant S. Gawli, Bhatu R. Patil, et al. · Lung Cancer · 13
Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017–2024)
2025 · Narendra R. Nagpure, Harun M. Patel · Expert Opinion on Therapeutic Patents · 10
Lazertinib: A Cardio‐Safer Alternative to Osimertinib for Epidermal Growth Factor Receptor L858R/T790M Double‐Mutant Tyrosine Kinase Resistant Non‐Small Cell Lung Cancer
2025 · Chandrakant S. Gawli, Narendra R. Nagpure, et al. · Drug Development Research · 4
Exploring Cannabidiol–TRPV3 Mediated Biological Activities—Findings From Molecular Docking, Simulation and Proteins Network Interactions
2025 · Jagdish Chand, Narendra Nagpure, et al. · Chemistry & Biodiversity · 4
Optimizing the Cardiotoxicity Profile of Osimertinib via Scaffold Hopping: An Integrated Cheminformatics and Molecular Modeling Approach
2026 · Narendra Nagpure, Vaibhav Kadam, et al. · Journal of Computational Biophysics and Chemistry · 1
In silico, in vitro, and in vivo assessment of chitosan-diltiazem nanoparticles against pulmonary fibrosis
2025 · Nandeeni Punase, Ganesh V. Jamdar, et al. · Therapeutic Delivery · 1
PDF
Beyond Antibodies: Glypican‐3‐Targeting Peptides for Precision Hepatocellular Carcinoma Theranostics
2026 · Narendra Raju Nagpure, Nitesh Mani Tripathi, et al. · Journal of Peptide Science
Quantitative Analysis of Flavokawain a by Derivative and Area Under Curve UV-Spectrophotometry
2026 · Vaishnavi Pawar, Vaibhav Kadam, et al. · Journal of Applied Spectroscopy
Works count: 9
Citation count: 33
H-index: 4
I10-index: 2
Year
Topic
Type